On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea, […]
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea Read More »
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) revealed disappointing results in a late-stage trial for its experimental next-generation obesity
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) shareholders sought to find out why such a high number of patients
Novo Nordisk’s Dosing in CagriSema Obesity Drug Trial Puzzles Investors Read More »
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals (NASDAQ: IONS) drug to treat a rare genetic disorder, making
Ionis Pharmaceuticals Gains FDA Approval for New Drug to Treat Rare Genetic Disorder Read More »
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
On Wednesday, the U.S. Food and Drug Administration approved Mesoblast’s (NASDAQ: MESO) cell therapy for treating a type of complication
US FDA Approves Mesoblast’s Cell Therapy for Graft-Versus-Host Disease Read More »
ZURICH – On Thursday, Novartis (NYSE: NVS), the Swiss pharmaceutical group, said it was winding up MorphoSys sites in Germany
Novartis Announces 330 Job Cuts as It Closes MorphoSys Sites Read More »
On Wednesday, the U.S. Food and Drug Administration classified a recall of Boston Scientific’s (NYSE: BSX) catheters used in a
FDA Classifies Recall of Boston Scientific Catheters as ‘Most Serious’ Read More »
On Wednesday, the U.S. Department of Justice announced a lawsuit accusing CVS Health (NYSE: CVS) of filling and billing federal
US Accuses CVS of Filling, Billing Government for Illegal Opioid Prescriptions Read More »
Copyright © 2024 abbonews.com
